🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the safety and efficacy of X-82 in...
Status
Terminated
Location
Multiple Locations
Start Date
2015-03-16
Trial ID
NCT02348359
This study will evaluate the effect of combination therapy with verteporfin...
Status
Terminated
Location
Novartis Investigative site
Start Date
2007-05
Trial ID
NCT00433017
Treatments Being Tested
Objectives: Primary objective: To evaluate the effects on retinal morphop...
Status
Unknown
Location
Retina and Vitreous service of the University Hospital, Faculty of Medicine of Ribeirão Preto-USP (HCFMRP)
Start Date
2012-02
Trial ID
NCT02005432
This is a 24-week, prospective, multi-center, open-label, randomized, inves...
Status
Terminated
Location
Toronto Retina Institue
Start Date
2015-11
Trial ID
NCT02684084
This study investigates the use of radiation to treat wet age-related macul...
Status
Completed
Location
Bristol Eye Hospital
Start Date
2014-12
Trial ID
NCT02243878
Treatments Being Tested
The purpose of this study is to evaluate the effects and safety of ranibizu...
Status
Unknown
Location
Beijing Aier Intech Eye Hospital
Start Date
2017-01
Trial ID
NCT02806752
Treatments Being Tested
To evaluate, specifically within the Canadian medical environment, the effi...
Status
Completed
Location
Calgary Retina Consultants
Start Date
2010-07
Trial ID
NCT01135914
Treatments Being Tested
The objectives of this study are to evaluate the safety and efficacy of int...
Status
Terminated
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT01940900
Treatments Being Tested
The objective of this clinical trial is to compare and evaluate the safety ...
Status
Unknown
Location
Hallym University Kangnam Sacred Heart Hospital
Start Date
2018-01-08
Trial ID
NCT03759860
To demonstrate the efficacy of ranibizumab in combination with reduced-flue...
Status
Completed
Location
Multiple Locations
Start Date
2012-06
Trial ID
NCT01968486
Treatments Being Tested